NIH-funded research R01 grant

Understanding liver disease in a family with severe conditions

Official title: Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family

Funded at University of California, San Francisco · NIH-11017802 · Data updated 2026-11-12

This study is looking at how stem cells from a family with serious liver issues can help us learn more about non-alcoholic fatty liver disease (NAFLD) and find new ways to treat it.

More NAFLD research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startFebruary 1, 2024
Project endNovember 30, 2027
Funding year2025
Award (this year)$602,955
NIH project number5R01DK132129-02
Project IDNIH-11017802 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals or families with a history of non-alcoholic fatty liver disease or related liver conditions.

Less likely to help

Patients without a genetic predisposition to liver disease or those with other unrelated health issues may not benefit from this research.

What this research studies

This research focuses on using patient-derived stem cells to model and understand non-alcoholic fatty liver disease (NAFLD) in a family affected by severe liver conditions. The researchers will differentiate induced pluripotent stem cells (iPSCs) into liver cells to study the disease mechanisms and identify novel genes that may contribute to NAFLD. By testing these genes, the research aims to uncover potential therapeutic targets and better understand the pathways involved in liver disease. This approach allows for a personalized investigation of the disease based on the unique genetic background of the family.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for patients suffering from NAFLD and related liver diseases.

How similar studies have gone: Previous research has shown promise in using patient-derived stem cells to model liver diseases, indicating that this approach has potential for success.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Mattis, Aras Nikodemas — University of California, San Francisco
  • Study coordinator: Mattis, Aras Nikodemas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.